所在地 Facebook お問い合わせ
  • 教室案内
  • 診療案内
  • 医療関係者の方へ
  • 研修案内
  • ホーム
医療関係者の方へ

業績一覧

論文業績

2015年

  1. Asamura H: Invited commentary. Ann Thorac Surg 99:981-2, 2015
  2. Asamura H: Invited commentary. Ann Thorac Surg 99:222-3, 2015
  3. Fujita Y, Yagishita S, Hagiwara K, et al: The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer. Mol Ther 23:717-27, 2015
  4. Kakinuma R, Muramatsu Y, Kusumoto M, et al: Solitary Pure Ground-Glass Nodules 5 mm or Smaller: Frequency of Growth. Radiology:141071, 2015
  5. Kamata T, Sakurai H, Nakagawa K, et al: Solitary fibrous tumor of the pleura: morphogenesis and progression. A report of 36 cases. Surg Today, 2015
  6. Kamata T, Yoshida A, Kosuge T, et al: Ciliated Muconodular Papillary Tumors of the Lung: A Clinicopathologic Analysis of 10 Cases. Am J Surg Pathol, 2015
  7. Kitazono S, Fujiwara Y, Tsuta K, et al: Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non-Small-Cell Lung Cancer. Clin Lung Cancer, 2015
  8. Miyanaga A, Masuda M, Tsuta K, et al: Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing. J Thorac Oncol 10:844-51, 2015
  9. Mizuno T, Okumura M, Asamura H, et al: Surgical management of recurrent thymic epithelial tumors: a retrospective analysis based on the Japanese nationwide database. J Thorac Oncol 10:199-205, 2015
  10. Sakurai H, Nakagawa K, Watanabe S, et al: Clinicopathologic features of resected subcentimeter lung cancer. Ann Thorac Surg 99:1731-8, 2015
  11. Suzuki M, Shiraishi K, Yoshida A, et al: HER2 gene mutations in non-small cell lung carcinomas: concurrence with Her2 gene amplification and Her2 protein expression and phosphorylation. Lung Cancer 87:14-22, 2015
  12. Watanabe Y, Kusumoto M, Yoshida A, et al: Surgically resected solitary cavitary lung adenocarcinoma: association between clinical, pathologic, and radiologic findings and prognosis. Ann Thorac Surg 99:968-74, 2015
  13. Yoshida Y, Sakamoto M, Maeda E, et al: Can image analysis on high-resolution computed tomography predict non-invasive growth in adenocarcinoma of the lung? Ann Thorac Cardiovasc Surg 21:8-13, 2015
  14. Kinoshita T, Ohtsuka T, Yotsukura M, et al: Prognostic impact of preoperative tumor marker levels and lymphovascular invasion in pathological stage I adenocarcinoma and squamous cell carcinoma of the lung. J Thorac Oncol 10:619-28, 2015
  15. Kinoshita T, Yoshida J, Ishii G, et al: The availability of pre- and intraoperative evaluation of a solitary pulmonary nodule in breast cancer patients. Ann Thorac Cardiovasc Surg 21:31-6, 2015
  1. 淺村尚生: 肺癌のリンパ節転移経路と廓清法に関する研究. 呼吸34:239-240, 2015
  2. 鎌田嗣正, 櫻井裕幸, 中川加寿夫, et al: 肺腫瘍との鑑別が困難であった特発性肺内血腫の2例. 日本呼吸器外科学会雑誌 29:73-77, 2015
  3. 鎌田嗣正, 淺村尚生: 【癌治療この10年(2004~2014年)、そして未来への展望】 外科領域 肺癌. 癌の臨床 60:597-602, 2015

2014年

  1. Asamura H: Role of limited sublobar resection for early-stage lung cancer: steady progress. J Clin Oncol 32:2403-4, 2014
  2. Asamura H, Watanabe S: In response to the review article in Surgery Today: JCOG trials for small adenocarcinomas of the lung. Surg Today 44:1593-4, 2014
  3. Bhora FY, Chen DJ, Detterbeck FC, et al: The ITMIG/IASLC Thymic Epithelial Tumors Staging Project: A Proposed Lymph Node Map for Thymic Epithelial Tumors in the Forthcoming 8th Edition of the TNM Classification of Malignant Tumors. J Thorac Oncol 9:S88-96, 2014
  4. De Ruysscher D, Nakagawa K, Asamura H: Surgical and nonsurgical approaches to small-size nonsmall cell lung cancer. Eur Respir J 44:483-94, 2014
  5. Detterbeck FC, Stratton K, Giroux D, et al: The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9:S65-72, 2014
  6. Eba J, Kenmotsu H, Tsuboi M, et al: A Phase III trial comparing irinotecan and cisplatin with etoposide and cisplatin in adjuvant chemotherapy for completely resected pulmonary high-grade neuroendocrine carcinoma (JCOG1205/1206). Jpn J Clin Oncol 44:379-82, 2014
  7. Filosso PL, European Society of Thoracic S, Neuroendocrine Tumors of The Lung W-G, et al: Knowledge of pulmonary neuroendocrine tumors: where are we now? Thorac Surg Clin 24:ix-xii, 2014
  8. Inoue M, Okumura M, Sawabata N, et al: Clinicopathological characteristics and surgical results of lung cancer patients aged up to 50 years: the Japanese Lung Cancer Registry Study 2004. Lung Cancer 83:246-51, 2014
  9. Kameyama K, Okumura N, Miyaoka E, et al: Prognostic value of intraoperative pleural lavage cytology for non-small cell lung cancer: the influence of positive pleural lavage cytology results on T classification. J Thorac Cardiovasc Surg 148:2659-64, 2014
  10. Kinno T, Tsuta K, Shiraishi K, et al: Clinicopathological features of nonsmall cell lung carcinomas with BRAF mutations. Ann Oncol 25:138-42, 2014
  11. Kondo K, Van Schil P, Detterbeck FC, et al: The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9:S81-7, 2014
  12. Masai K, Nakagawa K, Yoshida A, et al: Cytokeratin 19 expression in primary thoracic tumors and lymph node metastases. Lung Cancer 86:318-23, 2014
  13. Mizugaki H, Fujiwara Y, Yamamoto N, et al: Adjuvant chemotherapy in patients with completely resected small cell lung cancer: a retrospective analysis of 26 consecutive cases. Jpn J Clin Oncol 44:835-40, 2014
  14. Nakagawa K, Asamura H, Sakurai H, et al: Does the mode of surgical resection affect the prognosis/recurrence in patients with thymoma? J Surg Oncol 109:179-83, 2014
  15. Nicholson AG, Detterbeck FC, Marino M, et al: The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the T Component for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9:S73-80, 2014
  16. Novello S, Asamura H, Bazan J, et al: Early-stage lung cancer: 40s anniversary. J Thorac Oncol 9:1434-42, 2014
  17. Pass HI, Giroux D, Kennedy C, et al: Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee. J Thorac Oncol 9:856-64, 2014
  18. Rami-Porta R, Bolejack V, Giroux DJ, et al: The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer. J Thorac Oncol 9:1618-24, 2014
  19. Sakurai H, Asamura H: Sublobar resection for early-stage lung cancer. Transl Lung Cancer Res 3:164-72, 2014
  20. Sakurai H, Asamura H: Large-cell neuroendocrine carcinoma of the lung: surgical management. Thorac Surg Clin 24:305-11, 2014
  21. Sakurai H, Asamura H, Miyaoka E, et al: Differences in the prognosis of resected lung adenocarcinoma according to the histological subtype: a retrospective analysis of Japanese lung cancer registry data. Eur J Cardiothorac Surg 45:100-7, 2014
  22. Soma S, Tsuta K, Takano T, et al: Intratumoral distribution of EGFR-amplified and EGFR-mutated cells in pulmonary adenocarcinoma. Pathol Res Pract 210:155-60, 2014
  23. Takei H, Kondo H, Miyaoka E, et al: Surgery for small cell lung cancer: a retrospective analysis of 243 patients from Japanese Lung Cancer Registry in 2004. J Thorac Oncol 9:1140-5, 2014
  24. Tsuta K, Kawago M, Yoshida A, et al: Primary lung adenocarcinoma with morule-like components: a unique histologic hallmark of aggressive behavior and EGFR mutation. Lung Cancer 85:12-8, 2014
  25. Tsuta K, Kohno T, Yoshida A, et al: RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis. Br J Cancer 110:1571-8, 2014
  26. Watanabe Y, Shiraishi K, Takahashi F, et al: Biomarker expression and druggable gene alterations for development of an appropriate therapeutic protocol for pulmonary adenosquamous carcinoma. Histopathology, 2014
  27. Watanabe Y, Tsuta K, Kusumoto M, et al: Clinicopathologic features and computed tomographic findings of 52 surgically resected adenosquamous carcinomas of the lung. Ann Thorac Surg 97:245-51, 2014
  28. Yoshida A, Tsuta K, Ohno M, et al: STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. Am J Surg Pathol 38:552-9, 2014
  29. Yoshida A, Tsuta K, Wakai S, et al: Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers. Mod Pathol 27:711-20, 2014
  30. Kaseda K, Izumi Y, Hayashi Y, et al: Carcinoids among multiple lung tumorlets: carcinoids or aggregates of tumorlets? Pathol Int 64:91-3, 2014
  31. Kaseda K, Ohtsuka T, Hayashi Y, et al: Surgical treatment of a solitary pulmonary metastasis from eyelid sebaceous carcinoma: report of a case. World J Surg Oncol 12:108, 2014
  32. Kinoshita T, Ohtsuka T, Hato T, et al: Prognostic factors based on clinicopathological data among the patients with resected peripheral squamous cell carcinomas of the lung. J Thorac Oncol 9:1779-87, 2014
  33. Kohno M, Watanabe M, Goto T, et al: Attenuation of lung ischemia-reperfusion injury by rho-associated kinase inhibition in a rat model of lung transplantation. Ann Thorac Cardiovasc Surg 20:359-64, 2014
  34. Ohtsuka T, Kaseda K, Shigenobu T, et al: Carbon monoxide-releasing molecule attenuates allograft airway rejection. Transpl Int 27:741-7, 2014
  35. Okui M, Kohno M, Shigenobu T, et al: [Resection and reconstruction of sternum]. Kyobu Geka 67:38-43, 2014
  36. Shimoda M, Principe S, Jackson HW, et al: Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state. Nat Cell Biol 16:889-901, 2014
  37. Yotsukura M, Kinoshita T, Kamiyama I, et al: Temporary extravascular shunt for reconstruction of a superior vena cava invaded by a lung tumor. Ann Thorac Surg 98:2242-3, 2014
  38. Kamiyama I, Kohno M, Kamiya K, et al: A new technique of bronchial microsampling and proteomic analysis of epithelial lining fluid in a rat model of acute lung injury. Mol Immunol 59:217-25, 2014
  1. 淺村尚生: 1枚のシェーマ 上大静脈の再建 1本か2本か? 胸部外科 67:536, 2014
  2. 奥井将之, 河野光智, 重信敬夫, et al: 【胸壁・横隔膜の手術-その1】 胸壁再建法 胸骨切除・再建術の検討. 胸部外科 67:38-43, 2014
  3. 成毛聖夫, 大塚崇, 赤塚誠哉: 末梢肺に発生した類基底細胞型扁平上皮癌の1切除例. 日本呼吸器外科学会雑誌 28:56-59, 2014
  4. 奥井将之, 河野光智, 重信敬夫, et al: 【胸壁・横隔膜の手術-その1】 胸壁再建法 胸骨切除・再建術の検討. 胸部外科 67:38-43, 2014

2013年

  1. Asamura H, Hishida T, Suzuki K, et al: Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201. J Thorac Cardiovasc Surg 146:24-30, 2013
  2. Arai Y, Totoki Y, Takahashi H, et al: Mouse model for ROS1-rearranged lung cancer. PLoS One 8:e56010, 2013
  3. Detterbeck FC, Asamura H, Crowley J, et al: The IASLC/ITMIG thymic malignancies staging project: development of a stage classification for thymic malignancies. J Thorac Oncol 8:1467-73, 2013
  4. Kawago M, Sakurai H, Watanabe S, et al: [Pulmonary epithelioid hemangioendothelioma]. Kyobu Geka 66:142-5, 2013
  5. Kawase A, Yoshida J, Miyaoka E, et al: Visceral pleural invasion classification in non-small-cell lung cancer in the 7th edition of the tumor, node, metastasis classification for lung cancer: validation analysis based on a large-scale nationwide database. J Thorac Oncol 8:606-11, 2013
  6. Kobayashi S, Tsuta K, Sekine S, et al: Pulmonary neuroendocrine tumors with nuclear inclusion. Pathol Res Pract 209:574-7, 2013
  7. Masai K, Tsuta K, Kawago M, et al: Expression of squamous cell carcinoma markers and adenocarcinoma markers in primary pulmonary neuroendocrine carcinomas. Appl Immunohistochem Mol Morphol 21:292-7, 2013
  8. Miyanaga A, Honda K, Tsuta K, et al: Diagnostic and prognostic significance of the alternatively spliced ACTN4 variant in high-grade neuroendocrine pulmonary tumours. Ann Oncol 24:84-90, 2013
  9. Morita S, Yoshida A, Goto A, et al: High-grade lung adenocarcinoma with fetal lung-like morphology: clinicopathologic, immunohistochemical, and molecular analyses of 17 cases. Am J Surg Pathol 37:924-32, 2013
  10. Nakamura H, Tsuta K, Yoshida A, et al: Aberrant anaplastic lymphoma kinase expression in high-grade pulmonary neuroendocrine carcinoma. J Clin Pathol 66:705-7, 2013
  11. Nakazato Y, Maeshima AM, Ishikawa Y, et al: Interobserver agreement in the nuclear grading of primary pulmonary adenocarcinoma. J Thorac Oncol 8:736-43, 2013
  12. Noro R, Honda K, Tsuta K, et al: Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification. Ann Oncol 24:2594-600, 2013
  13. Oyama M, Miyagi Maeshima A, Tochigi N, et al: Prognostic impact of pleural invasion in 1488 patients with surgically resected non-small cell lung carcinoma. Jpn J Clin Oncol 43:540-6, 2013
  14. Rocco G, Allen MS, Altorki NK, et al: Clinical statement on the role of the surgeon and surgical issues relating to computed tomography screening programs for lung cancer. Ann Thorac Surg 96:357-60, 2013
  15. Tsuta K, Kawago M, Inoue E, et al: The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations. Lung Cancer 81:371-6, 2013
  16. Tsuta K, Mimae T, Nitta H, et al: Insulin-like growth factor-1 receptor protein expression and gene copy number alterations in non-small cell lung carcinomas. Hum Pathol 44:975-82, 2013
  17. Watanabe S, Asamura H, Miyaoka E, et al: Results of T4 surgical cases in the Japanese Lung Cancer Registry Study: should mediastinal fat tissue invasion really be included in the T4 category? J Thorac Oncol 8:759-65, 2013
  18. Yoshida A, Kohno T, Tsuta K, et al: ROS1-rearranged lung cancer: a clinicopathologic and molecular study of 15 surgical cases. Am J Surg Pathol 37:554-62, 2013
  19. Kinoshita T, Yoshida J, Ishii G, et al: The differences of biological behavior based on the clinicopathological data between resectable large-cell neuroendocrine carcinoma and small-cell lung carcinoma. Clin Lung Cancer 14:535-40, 2013
  1. 淺村尚生: IASLCとその活動. 腫瘍内科 11:94-96, 2013
  2. 中川加寿夫, 淺村尚生: 【リンパ節転移と郭清-癌腫別の意義】 UICC/TNM分類におけるリンパ節転移の位置づけ. 外科 75:690-694, 2013
  3. 川後光正, 櫻井裕幸, 渡辺俊一, et al: 肺類上皮血管内皮腫. 胸部外科 66:142-145, 2013
  4. 牧野崇, 淺村尚生: 【最新肺癌学-基礎と臨床の最新研究動向-】 肺癌の治療戦略 外科治療 I、II期肺癌に対する外科治療. 日本臨床 71:441-444, 2013
  5. 堀之内宏久, 渡辺真純, 河野光智, et al: 気管乳頭腫の治療経験. 日本気管食道科学会会報 64:425-429, 2013
  6. 神山育男, 澤藤誠: 上肢虚血性疾患に対し胸腔鏡下胸部交感神経節切除術が奏功した2例. 気管支学 35:14-18, 2013
  7. 神山育男, 澤藤誠: 集学的治療を行ったSomatic-type malignancyを伴う縦隔原発胚細胞性腫瘍の1例. 日本呼吸器外科学会雑誌 27:203-208, 2013
  8. 青木耕平, 澤藤誠, 神山育男, et al: 特発性線維性縦隔炎による上大静脈症候群に合併したDownhill esophageal varicesの1例. 日本呼吸器外科学会雑誌 27:642-649, 2013

2012年

  1. Hosako M, Muto T, Nakamura Y, et al: Proteomic study of malignant pleural mesothelioma by laser microdissection and two-dimensional difference gel electrophoresis identified cathepsin D as a novel candidate for a differential diagnosis biomarker. J Proteomics 75:833-44, 2012
  2. Kawaguchi K, Miyaoka E, Asamura H, et al: Modern surgical results of lung cancer involving neighboring structures: a retrospective analysis of 531 pT3 cases in a Japanese Lung Cancer Registry Study. J Thorac Cardiovasc Surg 144:431-7, 2012
  3. Maeshima AM, Tsuta K, Asamura H, et al: Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status. Cancer 118:4512-8, 2012
  4. Mimae T, Tsuta K, Kondo T, et al: Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas. Ann Oncol 23:3129-37, 2012
  5. Mimae T, Tsuta K, Maeshima AM, et al: Cathepsin D as a potential prognostic marker for lung adenocarcinoma. Pathol Res Pract 208:534-40, 2012
  6. Munakata W, Nomoto J, Takahashi N, et al: Carcinoma of donor origin after allogeneic peripheral blood stem cell transplantation. Am J Surg Pathol 36:1376-84, 2012
  7. Rusch VW, Asamura H: Response: a critique of the international association for the study of lung cancer lymph node map. J Thorac Oncol 7:481, 2012
  8. Rusch VW, Giroux D, Kennedy C, et al: Initial analysis of the international association for the study of lung cancer mesothelioma database. J Thorac Oncol 7:1631-9, 2012
  9. Tsuta K, Kozu Y, Mimae T, et al: c-MET/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas. J Thorac Oncol 7:331-9, 2012
  10. Van Schil PE, Asamura H, Rusch VW, et al: Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification. Eur Respir J 39:478-86, 2012
  11. Yoshino I, Yoshida S, Miyaoka E, et al: Surgical outcome of stage IIIA- cN2/pN2 non-small-cell lung cancer patients in Japanese lung cancer registry study in 2004. J Thorac Oncol 7:850-5, 2012
  12. Ohtsuka T, Goto T, Anraku M, et al: Dissection of lung parenchyma using electrocautery is a safe and acceptable method for anatomical sublobar resection. J Cardiothorac Surg 7:42, 2012
  13. Ohtsuka T, Okui M, Nakayama T, et al: Multiple segmentectomy for synchronous multiple small peripheral lung cancers: report of two cases. Ann Thorac Cardiovasc Surg 18:462-4, 2012
  14. Kinoshita T, Ishii G, Matsumura Y, et al: The recurrence of malignant pleural mesothelioma 14 years after extrapleural pneumonectomy: possible histological transformation. Pathol Int 62:754-7, 2012
  15. Kinoshita T, Yoshida J, Ishii G, et al: Pulmonary metastasis from encapsulated cervical ectopic type a thymoma. Ann Thorac Surg 94:e141-2, 2012
  16. Kohno M, Watanabe M, Izumi Y, et al: Mitigation of occult lung injury by pneumonectomy via minithoracotomy in mice. Thorac Cardiovasc Surg 60:124-30, 2012
  1. 淺村尚生, 川後光正: 【肺癌UPDATE】 診断 肺癌の新しいTNM病期分類(UICC-7). 医学のあゆみ 240:1107-1113, 2012
  2. 中川加寿夫, 淺村尚生: 【肺癌 実地医家に不可欠の最新の臨床知識とその活用】 セミナー/実地診療に必要な最新の診断・治療・管理の実際 新TNM分類の背景とその臨床適応の留意点. Medical Practice 29:930-934, 2012
  3. 川後光正, 淺村尚生: 【外科医のための癌診療データ】 臓器別最新データ 肺癌 肺癌の疫学. 臨床外科 67:42-45, 2012
  4. 東尚弘, 淺村尚生: 肺癌登録とQuality Indicator. 肺癌 52:72-76, 2012
  5. 柿沼龍太郎, 前島亜希子, 淺村尚生, et al: 【肺腺癌の診断と治療-新しい分類と臨床治療の変化-】 【肺腺癌の画像と治療】 肺腺癌放射線画像診断の進歩. 病理と臨床 30:520-524, 2012
  6. 櫻井裕幸, 淺村尚生: 【胸壁浸潤を伴った肺癌に対する集学的治療】 肺尖部胸壁浸潤肺癌に対する多モダリティー治療. 日本胸部臨床 71:429-436, 2012
  7. 澤端章好, 淺村尚生, 中西洋一, et al: 肺癌登録合同委員会における肺癌登録業務. 肺癌 52:77-79, 2012

2011年

  1. Asamura H: Identity, similarity, and difference between large cell neuroendocrine carcinoma and small cell carcinoma. J Thorac Oncol 6:1774; author reply 1776, 2011
  2. Asamura H: Surgery after induction chemotherapy or chemoradiotherapy for locally advanced lung cancer: a technical challenge. J Thorac Oncol 6:1458-9, 2011
  3. Kozu Y, Tsuta K, Kohno T, et al: The usefulness of mutation-specific antibodies in detecting epidermal growth factor receptor mutations and in predicting response to tyrosine kinase inhibitor therapy in lung adenocarcinoma. Lung Cancer 73:45-50, 2011
  4. Mimae T, Tsuta K, Takahashi F, et al: Steroid receptor expression in thymomas and thymic carcinomas. Cancer 117:4396-405, 2011
  5. Rice D, Rusch V, Pass H, et al: Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group. J Thorac Oncol 6:1304-12, 2011
  6. Sawabata N, Fujii Y, Asamura H, et al: [Lung cancer in Japan: analysis of lung cancer registry cases resected in 2004]. Nihon Kokyuki Gakkai Zasshi 49:327-42, 2011
  7. Sawabata N, Miyaoka E, Asamura H, et al: Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol 6:1229-35, 2011
  8. Suzuki K, Koike T, Asakawa T, et al: A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol 6:751-6, 2011
  9. Tochigi N, Tsuta K, Maeshima AM, et al: Malignant pulmonary epithelioid hemangioendothelioma with hilar lymph node metastasis. Ann Diagn Pathol 15:207-12, 2011
  10. Travis WD, Brambilla E, Noguchi M, et al: International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6:244-85, 2011
  11. Tsuta K, Tanabe Y, Yoshida A, et al: Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung. J Thorac Oncol 6:1190-9, 2011
  12. Wei S, Asamura H, Kawachi R, et al: Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification? J Thorac Oncol 6:310-8, 2011
  13. Yoshida A, Tsuta K, Nakamura H, et al: Comprehensive histologic analysis of ALK-rearranged lung carcinomas. Am J Surg Pathol 35:1226-34, 2011
  14. Yoshida A, Tsuta K, Nitta H, et al: Bright-field dual-color chromogenic in situ hybridization for diagnosing echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-positive lung adenocarcinomas. J Thorac Oncol 6:1677-86, 2011
  15. Ohtsuka T: [How I worked as a fellow in the University of Michigan Thoracic Surgery Program]. Nihon Geka Gakkai Zasshi 112:61-2, 2011
  1. 淺村尚生, 河内利賢, 大山真有美, et al: 開胸肺切除術後出血における出血量の推定 ドレーン排液量と再開胸時胸腔内血腫量は相関するか? 日本呼吸器外科学会雑誌 25:696-701, 2011
  2. 河内利賢, 淺村尚生: 【肺がん診療のPro & Con】 非小細胞肺がんに対する胸腔鏡手術 Con. 腫瘍内科 7:558-562, 2011
  3. 澤端章好, 藤井義敬, 淺村尚生, et al: 2004年肺癌外科切除例の全国集計に関する報告. 日本呼吸器外科学会雑誌 25:107-123, 2011

2010年

  1. Asamura H: Multiple primary cancers or multiple metastases, that is the question. J Thorac Oncol 5:930-1, 2010
  2. Kawachi R, Asamura H: A case of pulmonary epithelioid hemangioendothelioma. Jpn J Clin Oncol 40:709, 2010
  3. Maeshima AM, Tochigi N, Yoshida A, et al: Clinicopathologic analysis of multiple (five or more) atypical adenomatous hyperplasias (AAHs) of the lung: evidence for the AAH-adenocarcinoma sequence. J Thorac Oncol 5:466-71, 2010
  4. Maeshima AM, Tochigi N, Yoshida A, et al: Histological scoring for small lung adenocarcinomas 2 cm or less in diameter: a reliable prognostic indicator. J Thorac Oncol 5:333-9, 2010
  5. Nakamura K, Saji H, Nakajima R, et al: A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol 40:271-4, 2010
  6. Sakurai H, Asamura H, Goya T, et al: Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study. J Thorac Oncol 5:1594-601, 2010
  7. Sawabata N, Asamura H, Goya T, et al: Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002. J Thorac Oncol 5:1369-75, 2010
  8. Sawabata N, Asamura H, Goya T, et al: [A Japanese lung cancer registry study at 2002]. Nihon Kokyuki Gakkai Zasshi 48:333-44, 2010
  9. Shibata T, Kokubu A, Miyamoto M, et al: DEK oncoprotein regulates transcriptional modifiers and sustains tumor initiation activity in high-grade neuroendocrine carcinoma of the lung. Oncogene 29:4671-81, 2010
  10. Travis WD, Rekhtman N, Riley GJ, et al: Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift. J Thorac Oncol 5:411-4, 2010
  11. Kuroda H, Mochizuki S, Shimoda M, et al: ADAM28 is a serological and histochemical marker for non-small-cell lung cancers. Int J Cancer 127:1844-56, 2010
  1. 淺村尚生: 【肺癌新TNM分類を使用するにあたって】 肺癌新TNM病期分類(UICC-7)を使用するにあたって. 日本胸部臨床 69:479-486, 2010
  2. 淺村尚生: 【癌外科治療の日本と海外との相違点】 肺癌外科治療における日本と海外の違い. 臨床外科 65:772-775, 2010
  3. 淺村尚生: 【胸部の最新画像情報2010】 肺癌における新しいTNM病期分類(UICC-7)の成立と要点. 臨床放射線 55:1-9, 2010
  4. 淺村尚生: 【肺・胸膜腫瘍-分類と診断UPDATE】 肺癌における新しいTNM病期分類(UICC-7). 病理と臨床 28:114-120, 2010
  5. 櫻井裕幸, 淺村尚生: 【知っておきたい癌取扱い規約のポイント 日本と世界の違い】 肺癌. 外科治療 103:464-470, 2010
  6. 櫻井裕幸, 淺村尚生: 【がん治療のエビデンスと臨床試験】 肺癌. 外科治療 103:152-160, 2010
  7. 河内利賢, 淺村尚生: 肺癌の新TNM分類. 呼吸器内科 18:585-589, 2010
  8. 河内利賢, 淺村尚生: 肺癌の新TNM分類. 呼吸 29:795-799, 2010
  9. 河内利賢, 淺村尚生: 【肺癌 急速な変貌を遂げている肺癌診療の最新知識とその活用】 セミナー/肺癌診療の最新知識とその活用 新TNM分類とその意義. Medical Practice 27:1133-1138, 2010
  10. 澤端章好, 奥村明之進, 淺村尚生, et al: 肺癌登録合同委員会による肺癌登録の成果. 呼吸 29:1075-1081, 2010
  11. 澤端章好, 淺村尚生, 呉屋朝幸, et al: 2002年の肺癌治療例の全国集計に関する報告. 日本呼吸器外科学会雑誌 24:110-124, 2010
  12. 澤端章好, 藤井義敬, 淺村尚生, et al: 2004年肺癌外科切除例の全国集計に関する報告. 肺癌 50:875-888, 2010
  13. 渡辺真純, 野守裕明, 長谷川直樹, et al: 肺非結核性抗酸菌症の外科治療 非結核性抗酸菌症に対する肺切除術 特に多剤併用化学療法後の手術適応と成績. 結核 85:201-204, 2010